Ken S. Rosenthal

2.2k total citations · 1 hit paper
70 papers, 1.8k citations indexed

About

Ken S. Rosenthal is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Ken S. Rosenthal has authored 70 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Immunology, 21 papers in Molecular Biology and 21 papers in Epidemiology. Recurrent topics in Ken S. Rosenthal's work include Herpesvirus Infections and Treatments (17 papers), Immunotherapy and Immune Responses (11 papers) and T-cell and B-cell Immunology (9 papers). Ken S. Rosenthal is often cited by papers focused on Herpesvirus Infections and Treatments (17 papers), Immunotherapy and Immune Responses (11 papers) and T-cell and B-cell Immunology (9 papers). Ken S. Rosenthal collaborates with scholars based in United States, United Kingdom and Australia. Ken S. Rosenthal's co-authors include Paul E. Swanson, Daniel R. Storm, Daniel H. Zimmerman, Dan R. Storm, Joseph P. Kennedy, D C LaPorte, Raymond C. Fort, R. Subramanian, Gary K. Koski and B. George Barisas and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Annual Review of Biochemistry.

In The Last Decade

Ken S. Rosenthal

66 papers receiving 1.7k citations

Hit Papers

Polymyxin and Related Peptide Antibiotics 1977 2026 1993 2009 1977 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Polymyxin and Related Peptide Antibiotics
    1977 635 citations Ken S. Rosenthal et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ken S. Rosenthal United States 21 621 374 348 328 220 70 1.8k
Nobuo Kato Japan 23 627 1.0× 625 1.7× 303 0.9× 242 0.7× 181 0.8× 141 1.9k
Angus Bell Ireland 29 1.3k 2.0× 233 0.6× 361 1.0× 194 0.6× 359 1.6× 62 2.5k
Johnny X. Huang Australia 27 717 1.2× 153 0.4× 225 0.6× 349 1.1× 274 1.2× 48 1.8k
John P. Mueller United States 26 1.0k 1.7× 429 1.1× 212 0.6× 527 1.6× 148 0.7× 54 2.5k
Kok‐Fai Kong United States 19 1.0k 1.7× 444 1.2× 146 0.4× 425 1.3× 106 0.5× 25 2.1k
Xiaoxing Luo China 25 1.2k 1.9× 227 0.6× 113 0.3× 350 1.1× 259 1.2× 69 2.1k
Lloyd G. Czaplewski United Kingdom 21 981 1.6× 219 0.6× 126 0.4× 551 1.7× 357 1.6× 35 2.2k
Siobhán McClean Ireland 34 1.7k 2.7× 307 0.8× 390 1.1× 558 1.7× 477 2.2× 106 3.9k
Seiji Yamasaki Japan 32 1.4k 2.3× 491 1.3× 181 0.5× 710 2.2× 258 1.2× 124 3.4k
Travis B. Nielsen United States 20 776 1.2× 216 0.6× 259 0.7× 990 3.0× 56 0.3× 40 2.1k

Countries citing papers authored by Ken S. Rosenthal

Since Specialization
Citations

This map shows the geographic impact of Ken S. Rosenthal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken S. Rosenthal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken S. Rosenthal more than expected).

Fields of papers citing papers by Ken S. Rosenthal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken S. Rosenthal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken S. Rosenthal. The network helps show where Ken S. Rosenthal may publish in the future.

Co-authorship network of co-authors of Ken S. Rosenthal

This figure shows the co-authorship network connecting the top 25 collaborators of Ken S. Rosenthal. A scholar is included among the top collaborators of Ken S. Rosenthal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken S. Rosenthal. Ken S. Rosenthal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Rosenthal, Ken S., et al.. (2023). Ablative Treatment of Inflammatory and Other Diseases With Monoclonal Antibodies (Mabs) or Janus Kinases (Nibs) Increases Risk for Infection. Infectious Diseases in Clinical Practice. 31(6). 1 indexed citations
4.
Rosenthal, Ken S., et al.. (2022). The immune system through the ages. SHILAP Revista de lepidopterología. 6(3). 170–187.
5.
Rosenthal, Ken S.. (2020). Three Properties of SARS-CoV-2 That Promote COVID-19. Infectious Diseases in Clinical Practice. 28(6). 324–326. 2 indexed citations
6.
Rosenthal, Ken S.. (2018). Immune monitoring of the body’s borders. SHILAP Revista de lepidopterología. 2(3). 148–164.
7.
Rosenthal, Ken S., et al.. (2017). LEAPS Vaccine Incorporating HER-2/neu Epitope Elicits Protection That Prevents and Limits Tumor Growth and Spread of Breast Cancer in a Mouse Model. Journal of Immunology Research. 2017. 1–8. 8 indexed citations
8.
Rosenthal, Ken S. & Daniel H. Zimmerman. (2017). J-LEAPS vaccines elicit antigen specific Th1 responses by promoting maturation of type 1 dendritic cells (DC1). SHILAP Revista de lepidopterología. 1(2). 89–100. 2 indexed citations
9.
Rosenthal, Ken S., et al.. (2012). Artificial iris–intraocular lens implantation for traumatic aniridia and aphakia assisted by silicone oil retention sutures. Journal of Cataract & Refractive Surgery. 38(11). 2045–2048. 7 indexed citations
10.
Rosenthal, Ken S., Patricia R. Taylor, & Daniel H. Zimmerman. (2011). J‐LEAPS peptide and LEAPS dendritic cell vaccines. Microbial Biotechnology. 5(2). 203–213. 13 indexed citations
11.
Taylor, Philip R., Gary K. Koski, Christopher Paustian, et al.. (2010). J-LEAPS vaccines initiate murine Th1 responses by activating dendritic cells. Vaccine. 28(34). 5533–5542. 19 indexed citations
12.
Isayeva, Irada, et al.. (2003). Characterization and performance of membranes designed for macroencapsulation/implantation of pancreatic islet cells. Biomaterials. 24(20). 3483–3491. 41 indexed citations
13.
14.
Mao, Hongyi, et al.. (2002). The ability of an HSV strain to initiate zosteriform spread correlates with its neuroinvasive disease potential. Archives of Virology. 147(4). 763–773. 18 indexed citations
15.
Kennedy, Joseph P., et al.. (2000). Synthesis and characterization of tubular amphiphilic networks with controlled pore dimensions for insulin delivery. Designed Monomers & Polymers. 3(1). 113–122. 20 indexed citations
16.
Rosenthal, Ken S., et al.. (1997). The antiviral xanthate compound D609 inhibits herpes simplex virus type 1 replication and protein phosphorylation. Antiviral Research. 36(1). 63–72. 13 indexed citations
17.
Rosenthal, Ken S., et al.. (1991). Stabilization of clathrin coated vesicles by amantadine, tromantadine and other hydrophobic amines. FEBS Letters. 281(1-2). 188–190. 62 indexed citations
18.
Rosenthal, Ken S., Deborah A. Roess, & B. George Barisas. (1988). Herpes simplex virus type 1 penetration initiates mobilizaton of cell surface proteins. Biochimica et Biophysica Acta (BBA) - Biomembranes. 942(1). 38–44. 11 indexed citations
19.
Mohanty, Joy G. & Ken S. Rosenthal. (1985). A micropreparation of fluorescein conjugates of immunoglobulin G and fab from serum. Analytical Biochemistry. 146(2). 361–365. 1 indexed citations
20.
Rosenthal, Ken S., Dan R. Storm, & Warren T. Ford. (1975). Triethyl- n -Hexylammonium Triethyl- n -Hexylboride: a New Antimicrobial Showing Activity Against Candida albicans and Gram-Positive Bacteria. Antimicrobial Agents and Chemotherapy. 8(4). 510–512. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nobuo Kato Breakdown of academic impact, for papers by Angus Bell Breakdown of academic impact, for papers by Johnny X. Huang Breakdown of academic impact, for papers by John P. Mueller Breakdown of academic impact, for papers by Kok‐Fai Kong Breakdown of academic impact, for papers by Xiaoxing Luo Breakdown of academic impact, for papers by Lloyd G. Czaplewski Breakdown of academic impact, for papers by Siobhán McClean Breakdown of academic impact, for papers by Seiji Yamasaki Breakdown of academic impact, for papers by Travis B. Nielsen
Rankless by CCL
2026